Expert Opinion on Drug Metabolism & Toxicology

Expert Opinion on Drug Metabolism & Toxicology is a subscription-based, peer-reviewed journal published by Taylor & Francis, established in 2005, with a 2025 impact factor of 4.5（Expert Opinion on Drug Metabolism & Toxicology）是由（Taylor & Francis）出版的订阅制同行评审期刊，2005 年创刊，2025 年影响因子为 4.5。

Scope

• It publishes rigorously peer-reviewed review articles and original papers on all aspects of drug metabolism and toxicology该刊发表经严格同行评审的综述与原创论文，覆盖药物代谢与毒理学各方面。
• Reviews cover metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions and drug classes综述涵盖特定药物、药物相互作用与药物类别的代谢、药代动力学与毒理学问题。
• They also address the enzymes involved in the metabolism, disposition and excretion of drugs亦涉及参与药物代谢、处置与排泄的各类酶。
• The journal covers techniques and novel technologies for obtaining ADME-Tox data该刊涵盖获取（ADME-Tox）数据的技术与新技术。
• It publishes Drug Evaluations but does not publish case reports, case series or animal studies该刊发表药物评价，但不发表病例报告、病例系列或动物研究。

History

• The journal was established in 2005该刊于 2005 年创办。
• It is published by Taylor & Francis as a subscription-based, MEDLINE-indexed title该刊由（Taylor & Francis）出版，为订阅制刊物，被（MEDLINE）收录。
• Each article incorporates the author's own expert opinion on the impact of the topic on research and clinical practice每篇文章均纳入作者本人对该主题在研究与临床实践上影响的专家意见。
• It had a 2025 impact factor of 4.5 and addresses the needs of pharmacologists, clinical toxicologists and pharmaceutical scientists该刊 2025 年影响因子为 4.5，面向药理学家、临床毒理学家与制药科研人员。

Editors

• The editor-in-chief is Luis G. Valerio Jr of the U.S. Food and Drug Administration in Washington, DC现任主编为（Washington）的（U.S. Food and Drug Administration）的 Luis G. Valerio Jr。
• Valerio has served on the journal's advisory board since 2009 and as editor-in-chief since 2011Valerio 自 2009 年起任该刊顾问委员会成员，自 2011 年起任主编。
• Editorial board members span pharmacology, toxicology and regulatory science across Europe, North America and Asia编委横跨药理、毒理与规范科学领域，分布于欧洲、北美与亚洲。
• Manuscripts are peer reviewed, and the journal publishes reviews and drug evaluations rather than case reports or animal studies稿件经同行评审，该刊发表综述与药物评价，而不收录病例报告或动物研究。